Gut Microbiota in Children and Adolescents with Obesity
DOI:
https://doi.org/10.51699/cajmns.v7i3.3228Keywords:
gut microbiota, obesity, children, adolescents, metabolic syndrome, Firmicutes, Bacteroidetes, short-chain fatty acids, probiotics, dysbiosisAbstract
This article analyzes the structural and functional changes of the gut microbiota in children and adolescents with obesity, their impact on metabolic status, and their role in the pathogenesis of obesity. The results of the study show that intestinal dysbiosis, particularly changes in the Firmicutes/Bacteroidetes ratio, a decrease in beneficial bacteria such as Bifidobacterium and Lactobacillus, and an increase in pro-inflammatory microorganisms contribute to the development of obesity, insulin resistance, dyslipidemia, and metabolic syndrome. The article highlights, based on scientific sources, the role of the gut microbiota in energy metabolism, the production of short-chain fatty acids, the maintenance of intestinal barrier integrity, the regulation of immune response, and chronic inflammatory processes. According to the World Health Organization, in 2022, 160 million children and adolescents aged 5–19 years worldwide were affected by obesity, while 390 million were overweight. In Uzbekistan, in 2022, 13,743 cases of obesity were registered among children and adolescents aged 0–17 years, which represents a 23.8% increase compared to 2018. In addition, the article discusses probiotics, prebiotics, synbiotics, diet therapy, and innovative methods of gut microbiota modulation as promising approaches in the комплекс treatment of obesity. According to the study’s conclusions, early monitoring and targeted correction of the gut microbiota are of great importance in preventing obesity and its complications in children and adolescents.
References
O. V. Bocharova and E. D. Teplyakova, “Obesity in children and adolescents as a healthcare problem of the 21st century,” Kazan Medical Journal, vol. 101, no. 3, pp. 381–388, 2020, doi: 10.17816/KMJ2020-381.
T. S. Dushina, L. A. Suplotova, S. M. Klyashev, and M. V. Nikolenko, “Features of the relationship between gut microbiota parameters and clinical and biochemical indicators in young individuals with obesity,” Problems of Endocrinology, vol. 70, no. 4, pp. 84–93, 2024, doi: 10.14341/probl13454.
T. V. Tazina and L. V. Evsyukova, “Innovative approaches to obesity treatment: the use of synbiotic preparations for modulation of the gut microbiota,” Russian Medical Journal. Mother and Child, vol. 8, no. 3, pp. 215–222, 2025, doi: 10.32364/2618-8430-2025-8-3-6.
M. Yu. Shcherbakova, A. V. Vlasova, and T. A. Rozhivanova, “The role of the gut microbiota in the development of obesity in the age aspect,” Experimental and Clinical Gastroenterology, no. 2, pp. 11–16, 2015.
X. Yuan, R. Chen, K. L. McCormick, Y. Zhang, X. Lin, and X. Yang, “The role of the gut microbiota on the metabolic status of obese children,” Microbial Cell Factories, vol. 20, no. 1, p. 53, 2021, doi: 10.1186/s12934-021-01548-9.
World Obesity Federation, World Obesity Atlas 2023, 2023.
“Gut microbiota and obesity: pathogenetic relationships and ways to normalize intestinal microflora,” Therapeutic Archive, vol. 88, no. 9, pp. 135–142, 2016, doi: 10.17116/terarkh2016889135-142.
World Health Organization, “Obesity and overweight.” Geneva, Switzerland: WHO, 2025. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
World Health Organization Regional Office for Europe, Childhood Obesity Surveillance Initiative (COSI): Report on the Sixth Round of Data Collection, 2022–2024. Copenhagen, Denmark: WHO Europe, 2025. [Online]. Available: https://www.who.int/europe/ru/news/item/04-11-2025-childhood-obesity-and-overweight-remain-a-major-concern-across-the-region--new-who-report-finds
E. Cortés-Macías, M. Selma-Royo, K. Rio-Aige, C. Bäuerl, M. J. Rodríguez-Lagunas, C. Martínez-Costa, F. J. Pérez-Cano, and M. C. Collado, “Distinct breast milk microbiota, cytokine and adipokine profiles are associated with infant growth at 12 months: in vitro host-microbe interaction mechanistic approach,” Food & Function, vol. 14, no. 1, pp. 148–159, Jan. 2023, doi: 10.1039/D2FO02060B.
E. Cortés-Macías, M. Selma-Royo, C. Martínez-Costa, and M. C. Collado, “Breastfeeding practices influence the breast milk microbiota depending on pre-gestational maternal BMI and weight gain over pregnancy,” Nutrients, vol. 13, no. 5, p. 1518, 2021, doi: 10.3390/nu13051518.
E. Cortés-Macías, M. Selma-Royo, K. Rio-Aige, C. Bäuerl, M. J. Rodríguez-Lagunas, C. Martínez-Costa, F. J. Pérez-Cano, and M. C. Collado, “Distinct breast milk microbiota, cytokine, and adipokine profiles are associated with infant growth at 12 months: an in vitro host–microbe interaction mechanistic approach,” Food & Function, vol. 14, pp. 148–159, 2023.
M. R. Egamberdiyeva, D. M. Berdikulova, Sh. Sh. Azimova, N. U. Alimova, and A. A. Siddikov, “Analysis of the incidence and prevalence of obesity of children and adolescents by appeal for 5 years in the Republic of Uzbekistan,” doi: 10.5281/zenodo.12109350.
C. M. D. S. P. Indiani, K. F. Rizzardi, P. M. Castelo, L. F. C. Ferraz, M. Darrieux, and T. M. Parisotto, “Childhood obesity and Firmicutes/Bacteroidetes ratio in the gut microbiota: A systematic review,” Childhood Obesity, 2018, doi: 10.1089/chi.2018.0040.
T. A. Houtman, H. A. Eckermann, H. Smidt, and C. de Weerth, “Gut microbiota and BMI throughout childhood: the role of Firmicutes, Bacteroidetes, and short-chain fatty acid producers,” Scientific Reports, 2022, doi: 10.1038/s41598-022-07176-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Alimova Nasiba Usmanovna, Suleymanova Feruza Najmitdinovna, Xaitova Ziyodahon Qakhramon kizi, Rizayeva Shoxsanam Jaxongir kizi, Rizayeva Shoxsanam Jaxongir kizi, Shariksieva Mukhlisa Abrolovna, Kalanxodjaeva Shahnoza Baxtiyarovna

This work is licensed under a Creative Commons Attribution 4.0 International License.


